If you are considering hormone therapy for menopause symptoms, you may feel pulled in two directions. On one side, you may be tired of hot flashes, night sweats, poor sleep, brain fog, vaginal dryness, painful sex, or feeling unlike yourself. On the other side, you may have heard for years that hormones are dangerous. The answer is not to ignore your symptoms. It is also not to start hormones without a careful discussion. The answer is to understand the five things that matter most before making a decision.
1. The Type of Hormone Matters
The word “hormones” is too broad. Estrogen alone is different from estrogen combined with a progestogen. A woman who has had a hysterectomy may not need progesterone because she does not have a uterus. A woman who still has a uterus usually needs endometrial protection if she uses systemic estrogen. In the Women’s Health Initiative, long-term follow-up showed different breast cancer findings depending on the treatment group. Women with prior hysterectomy who used estrogen alone had lower breast cancer incidence and mortality compared with placebo, while women using estrogen plus medroxyprogesterone acetate had higher breast cancer incidence. Those details matter. Your plan should not be based on a headline.
2. Timing Matters
When hormone therapy is started can change the risk-benefit discussion. The Menopause Society states that for women younger than 60 or within 10 years of menopause onset, without contraindications, the benefit-risk ratio is favorable for treatment of bothersome hot flashes and night sweats and prevention of bone loss. That does not mean hormone therapy is right for everyone. It means the timing of treatment is part of the medical decision.
3. Route and Dose Matter
How estrogen is taken matters. Oral estrogen goes through the liver first. Transdermal estrogen, such as a patch, gel, or spray, is absorbed through the skin and may have a lower blood clot risk than oral estrogen. Dose matters too. The goal is usually to use the most appropriate effective option for your symptoms and risk profile, then reassess over time. This is why one person’s prescription should not automatically become another person’s plan.
4. Local Vaginal Estrogen Is Different
Many women avoid vaginal estrogen because they hear the word “estrogen” and think it carries the same risks as systemic hormone therapy. But low-dose vaginal estrogen is different. It is used directly in the vaginal and urinary tissues for symptoms such as vaginal dryness, painful sex, urinary discomfort, and recurrent urinary symptoms related to menopause. Because it is local, only very small amounts enter the bloodstream. For some women, local treatment may be all that is needed.
5. You Matter Most
There is no hormone prescription that is right for an entire room of women. Your symptoms matter. Your uterus status matters. Your age matters. Your time since menopause matters. Your breast cancer risk, heart risk, blood clot risk, blood pressure, cholesterol, blood sugar, bone health, medications, family history, and personal preferences all matter. The FDA’s 2025 hormone therapy labeling announcement reflected a more individualized approach to risk and benefit, rather than broad fear-based warnings for all women. Good menopause care should start with your full picture, not a yes-or-no question.
What If Hormones Are Not Right for You?
Hormones are not the only option. If hot flashes and night sweats are the main problem, systemic hormone therapy may be one option, but non-hormonal medications and lifestyle strategies may also help. If vaginal dryness, painful sex, or urinary symptoms are the main issue, local vaginal treatments may be enough. If hormones are not appropriate because of your medical history, or you simply do not want them, you still deserve treatment options.
Key Takeaways Before Starting Hormone Therapy
- Hormone therapy is not one-size-fits-all.
- Estrogen alone and estrogen plus a progestogen are different decisions.
- Timing, route, dose, and duration matter.
- Low-dose vaginal estrogen is different from systemic therapy.
- FDA-approved bioidentical options exist, including estradiol and micronized progesterone.
- Compounded hormones and pellets are not automatically safer.
- Your individual risks, symptoms, and goals should guide the plan.
Bottom Line
The question is not, “Are hormones good or bad?”
The better question is, “Which options make sense for this person, at this time, with this history and these goals?”
At InTouch Primary Care in Sugar Land, TX, we help women make informed menopause decisions based on symptoms, risks, medical history, and long-term prevention. Through our Direct Primary Care model, we have time to explain your options clearly and build a plan that fits your life.
Schedule your complimentary meet-and-greet here:
https://calendly.com/intouchprimarycare/15min?month=2024-02
FAQs: Starting Hormone Therapy
What should I know before starting hormone therapy?
You should understand your symptoms, uterus status, breast cancer risk, heart and blood clot risk, timing since menopause, and the difference between systemic and local treatment.
Are bioidentical hormones safer?
Not automatically. FDA-approved estradiol and micronized progesterone are bioidentical options. Compounded hormones are not automatically safer.
Do I need hormone therapy for menopause symptoms?
Not always. Some women benefit from hormone therapy, while others use non-hormonal medications, lifestyle strategies, or local vaginal treatments.
Schedule here
or call us to get started.